论文部分内容阅读
摘要目的放射诊断中,依据肝细胞癌的形态学亚型和生存预后,评估肝硬化病人合并人类免疫缺陷病毒(HIV)及丙型肝炎病毒(HCV)感染对肝细胞癌(HCC)的影响。方法机构伦理委员会批准该研究,病人签署书面知情同意。有两个数据库,一个用于HIV-HCV病人,另一个用于无HIV感染的HCV感染病人,病人来自前瞻性多中心群组。纳入标准为确诊肝硬化并在2008年1月—2012年12月间成像发现肝细胞癌。本研究包括35例HIV-HCV肝硬化病人(32例男
Abstract Objective To evaluate the effect of combined infection of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) on hepatocellular carcinoma (HCC) in patients with cirrhosis based on morphological subtypes and survival prognosis of hepatocellular carcinoma during radiodiagnosis. Methods Institutional Ethics Committee approved the study and patients signed written informed consent. There are two databases, one for HIV-HCV patients and the other for HCV-infected patients without HIV infection, with patients from a prospective, multicenter cohort. Inclusion criteria for the diagnosis of cirrhosis and imaging of hepatocellular carcinoma between January 2008 and December 2012 were included. This study included 35 patients with HIV-HCV cirrhosis (32 males